Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III randomized double-blind trial of flunarizine for prevention of pediatric migraine
2010-019947-21Phase 3Terminated
- Sponsor
- CAIBER
- Start
- Nov 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in migraine comparing Flunarizine with Placebo (2 arms). Primary endpoint: Number of migraine attacks every 4 weeks. Started Nov 2011; status: terminated.
02
Drugs
flunarizine
03
Conditions
migraine
Beyond the preview
Go deeper on 2010-019947-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019947-21.